Carl Abbott

423 total citations
8 papers, 95 citations indexed

About

Carl Abbott is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carl Abbott has authored 8 papers receiving a total of 95 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carl Abbott's work include Asthma and respiratory diseases (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Respiratory and Cough-Related Research (2 papers). Carl Abbott is often cited by papers focused on Asthma and respiratory diseases (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Respiratory and Cough-Related Research (2 papers). Carl Abbott collaborates with scholars based in United States, Canada and Australia. Carl Abbott's co-authors include Ellen Burgess, Peter Bolli, Donald W. McKay, Finlay A. McAlister, Thomas W. Wilson, George Honos, Martin G. Myers, Karen Mann, Sheldon W. Tobe and Steven A. Grover and has published in prestigious journals such as Annals of Pharmacotherapy, Canadian Journal of Cardiology and The Journal of Allergy and Clinical Immunology In Practice.

In The Last Decade

Carl Abbott

7 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Abbott United States	4	51	24	24	14	13	8	95
Jill Barton United Kingdom	4	41 0.8×	9 0.4×	14 0.6×	14 1.0×	8 0.6×	6	86
Peter Nilsson Sweden	5	82 1.6×	12 0.5×	21 0.9×	18 1.3×	4 0.3×	7	123
Charlie Harper United Kingdom	7	18 0.4×	28 1.2×	10 0.4×	12 0.9×	11 0.8×	16	125
Guido Cocci Italy	7	91 1.8×	44 1.8×	18 0.8×	6 0.4×	17 1.3×	8	152
M. Sadurní Spain	5	43 0.8×	21 0.9×	15 0.6×	5 0.4×	6 0.5×	15	85
Tsutomu Sunayama Japan	9	53 1.0×	35 1.5×	103 4.3×	4 0.3×	15 1.2×	23	151
Parounak Zelveian Russia	6	99 1.9×	46 1.9×	8 0.3×	11 0.8×	10 0.8×	31	133
Taishi Dotare Japan	7	47 0.9×	20 0.8×	78 3.3×	3 0.2×	15 1.2×	14	123
Arnold H. Boonstra Netherlands	6	38 0.7×	10 0.4×	10 0.4×	14 1.0×	29 2.2×	7	86
Érika Maria Gonçalves Campana Brazil	8	69 1.4×	9 0.4×	23 1.0×	40 2.9×	10 0.8×	26	160

Countries citing papers authored by Carl Abbott

Since Specialization

Citations

This map shows the geographic impact of Carl Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Abbott more than expected).

Fields of papers citing papers by Carl Abbott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Abbott. The network helps show where Carl Abbott may publish in the future.

Co-authorship network of co-authors of Carl Abbott

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Abbott. A scholar is included among the top collaborators of Carl Abbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Abbott. Carl Abbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Abbott, Carl, et al.. (2025). Olezarsen for the Treatment of Familial Chylomicronemia Syndrome. Annals of Pharmacotherapy. 59(11). 1031–1036. 2 indexed citations

Boulet, Louis‐Philippe, Carl Abbott, Guy Brusselle, et al.. (2024). Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1244–1253.e8. 2 indexed citations

Bogart, Michael, et al.. (2023). Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI. International Journal of COPD. Volume 18. 2367–2379.

Busse, William W., Carl Abbott, Guillaume Germain, et al.. (2022). Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. The Journal of Allergy and Clinical Immunology In Practice. 10(11). 2904–2913.e6. 16 indexed citations

Busse, William W., et al.. (2021). CAPTAIN: Effects of Asthma Onset in Childhood versus Adulthood on Response to Triple Therapy in Patients with Inadequately Controlled Asthma on Inhaled Corticosteroid/Long-Acting β2-Agonist. A1439–A1439. 1 indexed citations

Hemmelgarn, Brenda R., Finlay A. McAlister, Steven A. Grover, et al.. (2006). The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 22(7). 573–581. 40 indexed citations

Zarnke, Kelly B., Finlay A. McAlister, Norman R.C. Campbell, et al.. (2002). The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.. PubMed. 18(6). 604–24. 23 indexed citations

Zarnke, Kelly B., Finlay A. McAlister, N R Campbell, et al.. (2001). The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.. PubMed. 17(12). 1249–63. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact